ANI Pharmaceuticals, Inc.ANIPNASDAQ
Loading
Interest Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+16.1%
5Y CAGR+36.0%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+16.1%/yr
vs +17.4%/yr prior
5Y CAGR
+36.0%/yr
Recent deceleration
Acceleration
-1.3pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.6x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $43.90M | +149.4% |
| 2024 | $17.60M | -34.7% |
| 2023 | $26.94M | -4.0% |
| 2022 | $28.05M | +135.3% |
| 2021 | $11.92M | +26.1% |
| 2020 | $9.45M | -27.1% |
| 2019 | $12.97M | -12.1% |
| 2018 | $14.76M | +22.6% |
| 2017 | $12.04M | +6.3% |
| 2016 | $11.33M | - |